In May of 2012, John Eastman interviewed Tim Ruane, CEO of InSite Vision (INSV). Their discussion spanned the CEO’s experience in maneuvering in and out of the FDA, clinical trials, managing approved assets, and the CEO’s pragmatic approach towards medical fields and drug commercialization.  Below is the first segment of that interview, discussing the 47 [...]

Northwest Biotherapeutics, Inc. (NWBO.OB) is a development stage biotechnology company that develops and commercializes immunotherapy products that generate and enhance immune system responses to treat cancer. John Eastman interviewed Linda F. Powers, CEO for this article. JE: So tell me, how would you distinguish or set apart the type of work that Northwest is doing [...]

Lithium Exploration Group (LEXG_OTCBB) is a US based exploration and development company. Its focus is on the acquisition and development potential of lithium brines and other precious metals that demonstrate high probability for near-term production. Currently the company is gearing up for development of its Western Canada and South America properties, and investing in technology [...]